8th Annual Cell Culture and Bioprocessing Congress

Memo

We will welcome over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutionsOver 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies4 interactive streams:Cell Line DevelopmentPART 1: Early Cell Culture & Cell Line EngineeringPART 2: 3D Cell Culture Models & ApplicationsProcess Development: Upstream Bioprocessing and AnalyticsCell Line Development: Late Stage Cell Line Development, Stability, Data & Assay Data DevelopmentCell Culture and Downstream Bioprocessing14 pre-scheduled one to one meetings, exhibition and informal networking opportunitiesCo-located with our highly anticipated 6th Annual Stem Cell & Regenerative Medicine Congress, 5th Annual Cell & Gene Therapy Congress and 2nd Biobanking Congress.URLs:Tickets: https://go.evvnt.com/395613-2?pid=5569Brochure: https://go.evvnt.com/395613-3?pid=5569PriceRegistration available from: GBP 299.0Artists / Speakers: Christine DeMaria, Director, Cell Line Development, Sanofi,  Matthew Cheeks, Director of Biopharmaceutical Development, MedImmune,  Joachim Bar, Director Cell Culture Development, Boehringer Ingelheim,  Sagit Shalel Levanon, Associate Director, Bioprocess Technologies, Teva, Sarah Cox, Associate Director Biotherapeutics, Genomics Institute  of the Novartis Research FoundationTuesday October 29, 2019 at 7:30 am (ends Wednesday October 30, 2019 at 6:00 pm)Venue details: Hotel Novotel London West, Hammersmith International Ctre 1 Shortlands, Greater London W6 8DR, United Kingdom